Fidelity Funds - Global Healthcare Fund W-Acc-GBP

Category Sector Equity Healthcare
star-filledstar-filledstar-filled
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

£2.552

arrow-up£0.014 (+0.55%)

Fund Code

WGHFA

BJVDYK8

LU1033663300

Prices updated as at 21 May 2026
|
Prices in GBP
Investment objective
The fund aims to achieve capital growth over the long term. The fund invests at least 70% of its assets in equities of companies from anywhere in the world. The fund aims to make investments in companies that are involved in design, manufacture or sale of products and services in connection with health care, medicine or biotechnology.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide or Product Summary document
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Portfolio as of 30/04/2026

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Stock style

Large value

34.60%

% Weight
Value
Core
Growth
Large

35

22

23

Medium

6

10

3

Small

0

1

1

  • Interest rate risk

    Bond %
    Avg credit quality-
    Avg wtd coupon3.8
    Modified duration-

  • Credit quality breakdown

    Rating% of Bond
    No Data

Valuation

Fidelity Funds - Global Healthcare Fund W-Acc-GBP
Sector Equity Healthcare

17.67

17.67
18.77

1.69

1.69
1.85

4.11

4.11
4.21

14.42

14.42
9.17

Growth rate

Fidelity Funds - Global Healthcare Fund W-Acc-GBP
Sector Equity Healthcare

8.24%

8.24%
6.33%

1.58%

1.58%
1.65%

13.01%

13.01%
67.39%

Top 10 holdings

1
Roche Holding AG Ordinary Shares new
Sector
-
Country
Switzerland
% of assets
7.07393
2
Eli Lilly and Co
Sector
-
Country
United States
% of assets
6.98592
3
AstraZeneca PLC
Sector
-
Country
United Kingdom
% of assets
6.26891
4
AbbVie Inc
Sector
-
Country
United States
% of assets
6.1635
5
Stryker Corp
Sector
-
Country
United States
% of assets
5.27891
6
Novartis AG Registered Shares
Sector
-
Country
Switzerland
% of assets
5.05884
7
Gilead Sciences Inc
Sector
-
Country
United States
% of assets
4.51466
8
Thermo Fisher Scientific Inc
Sector
-
Country
United States
% of assets
4.32281
9
Boston Scientific Corp
Sector
-
Country
United States
% of assets
3.83158
10
UCB SA
Sector
-
Country
Belgium
% of assets
3.68193
Assets in top 10 holdings %

53.18%

Total no. of equity holdings

38.00

Total no. of bond holdings

-

Stock sectors

Fidelity Funds - Global Healthcare Fund W-Acc-GBP
Sector Equity Healthcare

0.14%

Basic materials

0.01%
-

Con cyclical

0.06%
-

Financial svs

0.07%
-

Real estate

0.01%
-

0.33%

Comm services

0.06%
-

Energy

0.02%
-

Industrials

0.05%
-

Technology

0.20%
-

99.53%

Con defensive

0.03%
-

Healthcare

99.49%
-

Utilities

0.01%
-


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2026 Morningstar. All rights reserved.